Literature DB >> 33445986

A Tale of Two Tails: Efficient Profiling of Protein Degraders by Specific Functional and Target Engagement Readouts.

Alexey L Chernobrovkin1, Cindy Cázares-Körner1, Tomas Friman1, Isabel Martin Caballero1, Daniele Amadio1, Daniel Martinez Molina1.   

Abstract

Targeted protein degradation represents an area of great interest, potentially offering improvements with respect to dosing, side effects, drug resistance, and reaching "undruggable" proteins compared with traditional small-molecule therapeutics. A major challenge in the design and characterization of degraders acting as molecular glues is that binding of the molecule to the protein of interest (PoI) is not needed for efficient and selective protein degradation; instead, one needs to understand the interaction with the responsible ligase. Similarly, for proteasome targeting chimeras (PROTACs), understanding the binding characteristics of the PoI alone is not sufficient. Therefore, simultaneously assessing the binding to both PoI and the E3 ligase as well as the resulting degradation profile is of great value. The cellular thermal shift assay (CETSA) is an unbiased cell-based method, designed to investigate the interaction of compounds with their cellular protein targets by measuring compound-induced changes in protein thermal stability. In combination with mass spectrometry (MS), CETSA can simultaneously evaluate compound-induced changes in the stability of thousands of proteins. We have used CETSA MS to profile a number of protein degraders, including molecular glues (e.g., immunomodulatory drugs) and PROTACs, to understand mode of action and to deconvolute off-target effects in intact cells. Within the same experiment, we were able to monitor both target engagement by observing changes in protein thermal stability as well as efficacy by simultaneous assessment of protein abundances. This allowed us to correlate target engagement (i.e., binding to the PoI and ligases) and functional readout (i.e., degrader induced protein degradation).

Entities:  

Keywords:  CETSA; IMiDS; PROTACs; TPP; cellular thermal shift assay; drug target; molecular glue

Mesh:

Substances:

Year:  2021        PMID: 33445986     DOI: 10.1177/2472555220984372

Source DB:  PubMed          Journal:  SLAS Discov        ISSN: 2472-5552            Impact factor:   3.341


  4 in total

Review 1.  Current Advances in CETSA.

Authors:  Tuomas Aleksi Tolvanen
Journal:  Front Mol Biosci       Date:  2022-06-09

2.  Discovery of novel KRAS‒PDEδ inhibitors with potent activity in patient-derived human pancreatic tumor xenograft models.

Authors:  Long Chen; Jing Zhang; Xinjing Wang; Yu Li; Lu Zhou; Xiongxiong Lu; Guoqiang Dong; Chunquan Sheng
Journal:  Acta Pharm Sin B       Date:  2021-07-19       Impact factor: 11.413

3.  Detection of thermal shift in cellular Keap1 by protein-protein interaction inhibitors using immunoblot- and fluorescence microplate-based assays.

Authors:  Sharadha Dayalan Naidu; Dina Dikovskaya; Terry W Moore; Albena T Dinkova-Kostova
Journal:  STAR Protoc       Date:  2022-04-01

4.  Real-Time Cellular Thermal Shift Assay to Monitor Target Engagement.

Authors:  Tino W Sanchez; Michael H Ronzetti; Ashley E Owens; Maria Antony; Ty Voss; Eric Wallgren; Daniel Talley; Krishna Balakrishnan; Sebastian E Leyes Porello; Ganesha Rai; Juan J Marugan; Samuel G Michael; Bolormaa Baljinnyam; Noel Southall; Anton Simeonov; Mark J Henderson
Journal:  ACS Chem Biol       Date:  2022-09-01       Impact factor: 4.634

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.